Skip to main content
ConductScienceScienceDex

Agadjanyan, Michael G

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #649
Unclaimed recordClaim profile
  • Rising Star
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$5.4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#649
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Agadjanyan, Michael G. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Agadjanyan, Michael G as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG074983-02R01Contact PI
    Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
    Institute for Molecular Medicine
    $2.4M
    award amount
  • 3U01AG060965-04S2U01Contact PI
    Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials
    Institute for Molecular Medicine
    $2.3M
    award amount
  • 3R01AG074983-02S1R01Contact PI
    Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
    Institute for Molecular Medicine
    $699K
    award amount

Award organization

Organizations that administered FY2023 awards listing Agadjanyan, Michael G as a PI.

FY2023 award administered by Institute for Molecular Medicine (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    Institute for Molecular Medicine
  2. 2009
    $500K Cumulative Funding
  3. 2010
    $1M Cumulative Funding
  4. 2014
    $2M Cumulative Funding
  5. 2014
    R01 Grant Holder
  6. 2015
    Entered Top 50% Nationally
    Ranked #3298
  7. 2015
    Entered Top 25% Nationally
    Ranked #3298
  8. 2016
    $5M Cumulative Funding
  9. 2016
    Program/Center Grant Leader
  10. 2018
    $10M Cumulative Funding
  11. 2018
    Entered Top 10% Nationally
    Ranked #572
  12. 2018
    Entered Top 5% Nationally
    Ranked #572
  13. 2023
    $25M Cumulative Funding

Explore further

Find collaborators for Agadjanyan, Michael G

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →